ETF Managers Group, LLC Cor Medix Inc. Transaction History
ETF Managers Group, LLC
- $2.78 Billion
- Q1 2023
A detailed history of ETF Managers Group, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, ETF Managers Group, LLC holds 13,706 shares of CRMD stock, worth $59,346. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,706
Previous 10,292
33.17%
Holding current value
$59,346
Previous $43,000
30.23%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CRMD
# of Institutions
95Shares Held
17.1MCall Options Held
92.9KPut Options Held
293K-
Black Rock Inc. New York, NY3.49MShares$15.1 Million0.0% of portfolio
-
Nomura Holdings Inc Tokyo, M02.95MShares$12.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.93MShares$12.7 Million0.0% of portfolio
-
Paul Singer Elliott Investment Management L.P. | West Palm Beach, Fl1.55MShares$6.71 Million0.04% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$5.12 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $178M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...